Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:50 AM
Ignite Modification Date:
2025-12-26 @ 11:50 AM
NCT ID:
NCT00789516
Eligibility Criteria:
Inclusion Criteria:
Group 1: beta thalassemia major or beta thalassemia / Hb E who receive regular transfusion therapy (Thal- RT). The baseline Hct was more than 24% for at least 6 months.
Group 2: beta thalassemia major or beta thalassemia / Hb E post SCT (Thal-SCT) who were discontinued immunosuppressive drugs.
Group 3: Normal children (NC) who had normal Hb/Hct and MCV for age
Exclusion Criteria:
Children with beta thalassemia major or beta thalassemia / Hb E who have co-diseases such as immune hemolytic anemia, infection, or inflammatory diseases
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
1 Year
Maximum Age:
18 Years
Study:
NCT00789516
Study Brief:
Protocol Section:
NCT00789516